AR015984A1 - Uso de antagonistas d1/d5, agonistas parciales d1/d5, mezclas de los mismos para la preparacion de un medicamento para reducir las ansias del consumo dealimento o sustancias adictivas en mamiferos y un kit que los comprende - Google Patents
Uso de antagonistas d1/d5, agonistas parciales d1/d5, mezclas de los mismos para la preparacion de un medicamento para reducir las ansias del consumo dealimento o sustancias adictivas en mamiferos y un kit que los comprendeInfo
- Publication number
- AR015984A1 AR015984A1 ARP980105373A ARP980105373A AR015984A1 AR 015984 A1 AR015984 A1 AR 015984A1 AR P980105373 A ARP980105373 A AR P980105373A AR P980105373 A ARP980105373 A AR P980105373A AR 015984 A1 AR015984 A1 AR 015984A1
- Authority
- AR
- Argentina
- Prior art keywords
- reduce
- antagonist
- food consumption
- antagonists
- kit
- Prior art date
Links
- 239000005557 antagonist Substances 0.000 title abstract 5
- 239000000126 substance Substances 0.000 title abstract 4
- 235000012631 food intake Nutrition 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 2
- 229940126601 medicinal product Drugs 0.000 title 1
- 239000004031 partial agonist Substances 0.000 title 1
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 abstract 4
- 241000124008 Mammalia Species 0.000 abstract 3
- 239000000556 agonist Substances 0.000 abstract 3
- 229960003920 cocaine Drugs 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 235000019788 craving Nutrition 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 1
- 229940125681 anticonvulsant agent Drugs 0.000 abstract 1
- 239000001961 anticonvulsive agent Substances 0.000 abstract 1
- 239000000935 antidepressant agent Substances 0.000 abstract 1
- 229940005513 antidepressants Drugs 0.000 abstract 1
- 239000003420 antiserotonin agent Substances 0.000 abstract 1
- 239000002249 anxiolytic agent Substances 0.000 abstract 1
- 230000000949 anxiolytic effect Effects 0.000 abstract 1
- 150000008038 benzoazepines Chemical class 0.000 abstract 1
- 230000003197 catalytic effect Effects 0.000 abstract 1
- 229940052760 dopamine agonists Drugs 0.000 abstract 1
- 239000003136 dopamine receptor stimulating agent Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 230000036651 mood Effects 0.000 abstract 1
- 239000000952 serotonin receptor agonist Substances 0.000 abstract 1
- 239000000021 stimulant Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Neurosurgery (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Addiction (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US95921397A | 1997-10-28 | 1997-10-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR015984A1 true AR015984A1 (es) | 2001-05-30 |
Family
ID=25501785
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP980105373A AR015984A1 (es) | 1997-10-28 | 1998-10-27 | Uso de antagonistas d1/d5, agonistas parciales d1/d5, mezclas de los mismos para la preparacion de un medicamento para reducir las ansias del consumo dealimento o sustancias adictivas en mamiferos y un kit que los comprende |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP1043980A2 (pt) |
| JP (1) | JP2001520989A (pt) |
| KR (1) | KR20010031470A (pt) |
| CN (1) | CN1283116A (pt) |
| AR (1) | AR015984A1 (pt) |
| AU (1) | AU1110099A (pt) |
| BR (1) | BR9814830A (pt) |
| CA (1) | CA2308453A1 (pt) |
| CO (1) | CO4970824A1 (pt) |
| HU (1) | HUP0100115A2 (pt) |
| IL (1) | IL135659A0 (pt) |
| NO (1) | NO20002149L (pt) |
| PE (1) | PE122299A1 (pt) |
| SK (1) | SK5812000A3 (pt) |
| WO (1) | WO1999021540A2 (pt) |
| ZA (1) | ZA989786B (pt) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6410527B1 (en) * | 1998-03-02 | 2002-06-25 | Schering Corporation | Method of treating obsessive compulsive disorders, somatoform disorders, dissociative disorders, eating disorders, impulse control disorders, and autism |
| PE20000333A1 (es) * | 1998-03-02 | 2000-05-13 | Schering Corp | Metodo para tratar desordenes compulsivos obsesivos, desordenes somatoformes, desordenes disociativos, desordenes al comer, desordenes de control de impulso y autismo |
| US6890951B2 (en) | 1998-08-05 | 2005-05-10 | Brookhaven Science Associates Llc | Treatment of addiction and addiction-related behavior |
| US6541520B1 (en) | 1998-08-05 | 2003-04-01 | Brookhaven Science Associates | Treatment of addiction and addiction-related behavior |
| IL137937A0 (en) * | 1999-08-27 | 2001-10-31 | Pfizer Prod Inc | A pharmaceutical composition for the prevention and treatment of nicotine addiction in a mammal |
| US6395783B1 (en) | 2000-10-23 | 2002-05-28 | Brookhaven Science Associates, Llc | Treatment of PCP addiction and PCP addiction-related behavior |
| US6462084B1 (en) | 2001-05-14 | 2002-10-08 | Brookhaven Science Associates, Llc | Treatment for obsessive-compulsive disorder (OCD) and OCD-related disorders using GVG |
| DE60231896D1 (de) | 2001-11-05 | 2009-05-20 | Krele Pharmaceuticals Llc | Zusammensetzungen und verfahren zur erhöhung der compliance mit therapien unter verwendung von aldehyddehydrogenase-hemmern und zur behandlung von alkoholsmus |
| JP6355921B2 (ja) | 2010-09-01 | 2018-07-11 | トニックス ファーマスーティカルズ, インコーポレイテッドTONIX Pharmaceuticals, Inc. | コカイン嗜癖の治療 |
| AU2013289922B2 (en) | 2012-07-12 | 2016-12-15 | Psyadon Pharmaceuticals, Inc. | Fused benzazepines for treatment of Tourette's Syndrome |
| SMT202000398T1 (it) * | 2013-10-18 | 2020-09-10 | Emalex Biosciences Inc | Benzazepine fuse per il trattamento della balbuzie |
| CN110327350B (zh) * | 2019-07-11 | 2021-02-23 | 温州医科大学 | 多巴胺d1受体拮抗剂sch39166在作为制备治疗眼部病理性血管新生药物的应用 |
| CN110833621A (zh) * | 2019-12-06 | 2020-02-25 | 中国医科大学 | 多巴胺受体1拮抗剂在制备治疗对氯胺酮致小鼠类精神分裂症药物上的应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5607967A (en) * | 1994-10-27 | 1997-03-04 | Merck & Co., Inc. | Treatment of alzheimer's disease with 5-(tetradecyloxy)-2-furan carboxylic acid |
| AU3408097A (en) * | 1996-06-06 | 1998-01-05 | Ergo Research Corporation | Treatment of lipid and glucose metabolism disorders with dopamine and seroto nin agonists |
-
1998
- 1998-10-26 KR KR1020007004505A patent/KR20010031470A/ko not_active Withdrawn
- 1998-10-26 BR BR9814830-3A patent/BR9814830A/pt not_active Application Discontinuation
- 1998-10-26 CN CN98812730A patent/CN1283116A/zh active Pending
- 1998-10-26 SK SK581-2000A patent/SK5812000A3/sk unknown
- 1998-10-26 AU AU11100/99A patent/AU1110099A/en not_active Abandoned
- 1998-10-26 JP JP2000517699A patent/JP2001520989A/ja not_active Withdrawn
- 1998-10-26 HU HU0100115A patent/HUP0100115A2/hu unknown
- 1998-10-26 IL IL13565998A patent/IL135659A0/xx unknown
- 1998-10-26 CO CO98062495A patent/CO4970824A1/es unknown
- 1998-10-26 CA CA002308453A patent/CA2308453A1/en not_active Abandoned
- 1998-10-26 EP EP98953826A patent/EP1043980A2/en not_active Withdrawn
- 1998-10-26 WO PCT/US1998/022255 patent/WO1999021540A2/en not_active Ceased
- 1998-10-27 AR ARP980105373A patent/AR015984A1/es unknown
- 1998-10-27 PE PE1998001010A patent/PE122299A1/es not_active Application Discontinuation
- 1998-10-27 ZA ZA989786A patent/ZA989786B/xx unknown
-
2000
- 2000-04-27 NO NO20002149A patent/NO20002149L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999021540B1 (en) | 1999-10-28 |
| SK5812000A3 (en) | 2000-12-11 |
| HUP0100115A2 (hu) | 2001-06-28 |
| JP2001520989A (ja) | 2001-11-06 |
| NO20002149L (no) | 2000-06-26 |
| WO1999021540A3 (en) | 1999-09-02 |
| CA2308453A1 (en) | 1999-05-06 |
| AU1110099A (en) | 1999-05-17 |
| ZA989786B (en) | 1999-04-28 |
| NO20002149D0 (no) | 2000-04-27 |
| EP1043980A2 (en) | 2000-10-18 |
| PE122299A1 (es) | 1999-12-04 |
| CN1283116A (zh) | 2001-02-07 |
| IL135659A0 (en) | 2001-05-20 |
| KR20010031470A (ko) | 2001-04-16 |
| WO1999021540A2 (en) | 1999-05-06 |
| CO4970824A1 (es) | 2000-11-07 |
| BR9814830A (pt) | 2000-10-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR015984A1 (es) | Uso de antagonistas d1/d5, agonistas parciales d1/d5, mezclas de los mismos para la preparacion de un medicamento para reducir las ansias del consumo dealimento o sustancias adictivas en mamiferos y un kit que los comprende | |
| Doogan et al. | Sertraline: a new antidepressant. | |
| Cardenas et al. | 5HT4 receptors couple positively to tetrodotoxin-insensitive sodium channels in a subpopulation of capsaicin-sensitive rat sensory neurons | |
| Ma et al. | Glucagon stimulates exocytosis in mouse and rat pancreatic α-cells by binding to glucagon receptors | |
| ES2151672T3 (es) | Composiciones de rapida disolucion oral para agonistas de dopamina. | |
| Hassell et al. | Drug-induced gingival overgrowth: old problem, new problem | |
| ES2120067T3 (es) | Metodos para inducir tolerancia de celulas t antigeno especifica. | |
| FI960727A0 (fi) | Neurokiniiniantagonisteina käyttökelpoiset heterosyklit | |
| CY1110260T1 (el) | Στερεες φαρμακευτικες συνθεσεις οι οποιες περιλαμβανουν εναν αγωνιστη υποδοχεα s1p και μια αλκοολη σακχαρων | |
| EA200100541A1 (ru) | Фармацевтическая композиция с модифицированным высвобождением сенсибилизатора к инсулину и других антидиабетических агентов | |
| SV2002000969A (es) | Composicion parenteral reconstituible | |
| AR038202A1 (es) | Compuestos de indazol utiles como inhibidores de la proteina quinasa | |
| Holladay et al. | Developmental immunotoxicology | |
| Sanchez et al. | The selective σ2 ligand Lu 28-179 has an antidepressant-like profile in the rat chronic mild stress model of depression | |
| Javanmard Khameneh et al. | The inflammasome adaptor ASC intrinsically limits CD4+ T-cell proliferation to help maintain intestinal homeostasis | |
| AR022839A1 (es) | Antagonistas de la integrina alfavbeta3 en combinacion con agentes quimioterapeuticos | |
| CR6581A (es) | Pirrolcarboxamidas fundido, receptores cerebrales gaba | |
| Call et al. | In vivo enhancement of peptide display by MHC class II molecules with small molecule catalysts of peptide exchange | |
| ES2187489T3 (es) | Composiciones farmaceuticas a base de diclofenac. | |
| AR024232A1 (es) | Bromhidrato de eletriptan monohidratado, composicion farmaceutica, su uso en la preparacion de medicamentos y procedimiento para su preparacion | |
| EA199901116A1 (ru) | Композиция, включающая 5-[4-[2-(n-метил-n-2-пиридил)-амино)этокси]бензил]тиазолидин-2,4-дион | |
| AR004093A1 (es) | El uso de una proteina derivada de una quimioquina de mamifero y un medicamento util para movilizar celulas tronco hematopoyeticas. | |
| NO944214L (no) | Farmasöytiske preparater for rektal administrering, inneholdende alkylsulfonamider som er HT1-agonister | |
| PE20040670A1 (es) | Nuevas composiciones farmaceuticas que contienen ambroxol y yoduro de isopropamida | |
| AU621705B2 (en) | Evaluative means for detecting inflammatory reactivity |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |